Transgenic Mice With Increased Expression of VEGF in RPE Cells

Peter Campochiaro, MD
The Johns Hopkins University (Baltimore, MD)
Year Awarded:
2000
Grant Duration:
April 1, 2000 to March 31, 2001
Disease:
Macular Degeneration
Award Amount:
$37,500
Grant Reference ID:
M2000027
Award Type:
Standard
Award Region:
US Northeastern

Transgenic Mice With Increased Expression of VEGF in RPE Cells

Details

Vascular Endothelial Cell Growth Factor (VEGF) is a powerful growth factor that induces neovascularization (the formation of new blood vessels) beneath the eye's retina. Because choroidal neovascularization (CNV) occurs in age-related macular degeneration, several researchers have been interested in the possible causative role of VEGF. Dr. Campochiaro has succeeded in creating a transgenic breed of mouse that expresses VEGF in photoreceptors. Although VEGF is produced in proximity to the choroid (a layer of cells just beneath the retina where neovascularization occurs in humans), CNV does not occur in the mice. Dr. Campochiaro hypothesizes that the retinal pigmented epithelial (RPE) cells prevent the VEGF from reaching the choroidal layer. In this continuation of last year's study, he is now testing this hypothesis by producing another transgenic mouse that produces VEGF in RPE cells in order to determine if they develop CNV. If they do, these mice will be important tools in studying CNV and for testing new therapies to halt or prevent neovascularization.
Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.